# Xtant Medical Holdings, Inc.: Form 10-K/A for the period ended Dec 31, 2017

- Company: [Xtant Medical Holdings, Inc.](/companies/xtnt.md) (CIK 1453593)
- Form: 10-K/A
- Filed: 2018-04-05
- Accepted by EDGAR: Apr 5, 2018, 15:06 ET
- Period: 2017-12-31
- Accession: 0001144204-18-019363
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1453593/000114420418019363/tv490179_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1453593/000114420418019363/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2017-01-01 to 2017-12-31 | $32.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2017-01-01 to 2017-12-31 | $50.1m | us-gaap:GrossProfit |
| Research and development | 12 months, 2017-01-01 to 2017-12-31 | $2.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | −$37.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2017-01-01 to 2017-12-31 | $14.7m | us-gaap:InterestExpense |
| Income tax | 12 months, 2017-01-01 to 2017-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | −$52.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | −$34.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2017-01-01 to 2017-12-31 | −$34.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2017-01-01 to 2017-12-31 | 1,507,769 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2017-01-01 to 2017-12-31 | −$543.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-01-01 to 2017-12-31 | $1.6m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2017-12-31 | $2.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-12-31 | $39.5m | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $105.7m | us-gaap:Assets |
| Current liabilities | at 2017-12-31 | $25.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-12-31 | $164.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-12-31 | −$58.7m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1453593/000114420418019363/tv490179_10ka.htm

Filed Apr 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001144204-18-019363. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.
